ライフサイエンスコーパス: QCA

1 QCA and IVUS studies were performed before and after int

2 QCA and optical coherence tomographic analyses were perf

3 QCA and QCU measurements of 1.5- to 2.5-mm residual lume

4 QCA can be used as an accurate method of poststent asses

5 QCA demonstrated a 15% increase in coronary artery diame

6 QCA measurements included minimal luminal diameter and d

7 QCA measurements included minimum lumen diameter (MLD) a

8 QCA systematic error (SE) varied from 0.01 for the Wikto

9 3-QCA was likely formed through oxidative ring cleavage an

10 ation product, 3-quinolinecarboxylic acid (3-QCA), was identified by liquid chromatography high resol

11 oducts were formed via covalent binding of 3-QCA with DOM molecules of above-average O/C and H/C rati

12 )(R432Q,R440A) mutant, yielding the 5-HT(3A)(QCA) construct with a gamma of 17.7 +/- 0.4 pS.

13 Modification of 5-HT(3A)(QCA) receptors by MTSEA or 2-(trimethylammonium) ethyl-M

14 y (tau = 15 s) reduced the gamma of 5-HT(3A)(QCA) receptors in inside-out patches, an effect reversed

15 exahydro-1H-cyclop enta[h]quinolin-3-one 3d (QCA-1093) as a novel nonsteroidal glucocorticoid recepto

16 rty necessary for their use as elements of a QCA device.

17 ent between multidetector CT angiography and QCA to detect a coronary stenosis of at least 50%.

18 (P < .001) with disagreement between CTA and QCA in multivariable analysis after controlling for sex,

19 stenosis between clinical interpretation and QCA and a Cohen weighted kappa statistic.

20 stenosis between clinical interpretation and QCA was 8.2+/-8.4%, reflecting an average higher percent

21 here was a good correlation between MDCT and QCA percent stenosis (r = 0.75, p < 0.01, SEE = 15%).

22 man correlation coefficient between MSCT and QCA was 0.76 (p < 0.0001).

23 with severity of atherosclerosis by MSCT and QCA.

24 be assessed quantitatively by both MSCT and QCA.

25 entional quantitative coronary angiographic (QCA) and intravascular ultrasound (IVUS) predictors of r

26 lidity of quantitative coronary angiography (QCA) after stent placement has been questioned because t

27 ned using quantitative coronary angiography (QCA) and an intracoronary Doppler-tipped guidewire.

28 performed quantitative coronary angiography (QCA) and intravascular ultrasound (IVUS) in 37 lesions w

29 Complete quantitative coronary angiography (QCA) and IVUS were obtained in 104 patients before and a

30 combined quantitative coronary angiography (QCA) and single-photon emission CT (SPECT) or QCA alone.

31 ent using quantitative coronary angiography (QCA) in 175 randomly selected patients undergoing electi

32 The quantitative coronary angiography (QCA) reference diameter (3.91 +/- 0.76 mm, mean +/- 1 SD

33 enosis by quantitative coronary angiography (QCA).

34 by using quantitative coronary angiography (QCA).

35 based on quantitative coronary angiography (QCA).

36 MSCT) and quantitative coronary angiography (QCA).

37 1 days of quantitative coronary angiography (QCA).

38 mpared to quantitative coronary angiography (QCA).

39 IVUS) and quantitative coronary angiography (QCA).

40 aboratory quantitative coronary angiography (QCA).

41 Using quantitative angiography (QCA) and intravascular ultrasound (IVUS), we studied 107

42 e >0.8 or quantitative coronary angiography [QCA] showing no percentage diameter stenosis >/=70% in 1

43 The quantum-dot cellular automata (QCA) approach offers an attractive alternative in which

44 of the molecular quantum cellular automata (QCA) cell array by the electric field from the Fe(III)-R

45 ementation of quantum-dot cellular automata (QCA) molecular computing.

46 ary diameter (2.69 +/- 0.33 mm) at baseline (QCA of three segments of LAD and three segments of left

47 ktor groups, there was no difference between QCA and QCU diameters.

48 he results demonstrated that type II binding QCA analogues were metabolically less stable (2- to 12-f

49 true" diameters of any stented lumen by both QCA and quantitative ultrasonic (QCU) measurement postst

50 By QCA, 25 women (27%) had > or = 50% coronary stenosis, in

51 ical interpretation, 56 (26.3%) were <70% by QCA, although none were <50%.

52 ereas approximately one quarter were <70% by QCA.

53 e 16 (94%) transplant patients classified by QCA as having occlusive coronary artery disease and 29 o

54 were euthanized at day 28, and evaluation by QCA revealed a significant improvement in mean lumen los

55 Of the 791 segments identified by QCA, 754 (95%) were analyzable by MDCT.

56 nts were largest for intermediate lesions by QCA (50% to <70%), with variation existing across sites.

57 rvention as more severe than measurements by QCA.

58 m lumen diameter (MLD) (2.26 +/- 0.82 mm) by QCA correlated less well with IVUS (2.8 +/- 0.82 mm, r =

59 gments with >20% coronary artery stenosis by QCA but also in 12 (15%) of 80 segments without angiogra

60 t the type II binding quinoline carboxamide (QCA) compounds were metabolically less stable.

61 l lumen and arterial area); 2) follow-up DS (QCA lesion length); and 3) follow-up MLD (QCA lesion len

62 66 segments of the radial graft on the first QCA study was 0.170 mm (95% confidence interval [CI] 0.1

63 In that instance, QCA may underestimate the luminal diameter.

64 S (QCA lesion length); and 3) follow-up MLD (QCA lesion length and preinterventional MLD and DS and I

65 e molecular system which acts as a molecular QCA cell.

66 There was no QCA inaccuracy for a 3.0-mm lumen within the Palmaz-Scha

67 transformations, we synthesized a library of QCA compounds that could undergo N-dealkylation, O-dealk

68 Univariate and multivariate predictors of QCA restenosis (> or = 50% diameter stenosis at follow-u

69 CA) and single-photon emission CT (SPECT) or QCA alone.

70 0-mm residual lumen within the Wiktor stent, QCA underestimated the luminal size by -0.1 mm.

71 The QCA DS measured 42 +/- 16%.

72 The QCA reference decreased from 3.51 +/- 0.46 mm to 3.22 +/

73 Finally, for the QCA analogues with aza-heteroaromatic rings, we did not

74 tent tissue burden, was not reflected in the QCA measurements, and may contribute to recurrence.

75 CA and SPECT and 64% (59 of 92) according to QCA alone.

76 lence of CAD was 39% (36 of 92) according to QCA and SPECT and 64% (59 of 92) according to QCA alone.

77 evaluate CTA diagnostic accuracy compared to QCA in patients according to calcium score and pre-test

78 c accuracy of 64-slice MSCT in comparison to QCA in a broad spectrum of patients.

79 476 Palmaz-Schatz stents for whom follow-up QCA data were available 5.5 +/- 4.8 months (mean +/- SD)

80 When compared with QCA alone, diagnostic accuracy of CT perfusion and MR pe

81 When compared with QCA and SPECT, per-patient diagnostic accuracy of perfus

82 tive predictive values of MDCT compared with QCA for the detection of segments with significant (>50%